Lactobacillus rhamnosus Strains Relieve Loperamide-Induced Constipation via Different Pathways Independent of Short-Chain Fatty Acids

Gang Wang,Shurong Yang,Shanshan Sun,Qian Si,Linlin Wang,Qiuxiang Zhang,Gaojue Wu,Jianxin Zhao,Hao Zhang,Wei Chen
DOI: https://doi.org/10.3389/fcimb.2020.00423
IF: 6.073
2020-08-19
Frontiers in Cellular and Infection Microbiology
Abstract:Increasing researches have confirmed the relationship between slow-transit constipation and gut microbiota dysbiosis. Many population and animal experiments have identified probiotics as effectors for the relief of constipation symptoms, but the specific mechanism remains unclear. In this intervention study, <i>Lactobacillus rhamnosus</i> strains isolated from five different sources were administered to mice with loperamide-induced constipation, and the impacts of these strains on constipation-related indicators were evaluated. All five strains of <i>L. rhamnosus</i> were found to improve constipation to various degrees. However, contrary to previous studies, the abilities of <i>L. rhamnosus</i> strains to improve constipation symptoms were not associated with the levels of short-chain fatty acids (SCFAs) in the colon. The effects of different strains of <i>L. rhamnosus</i> on constipation relief were associated with different aspects of the GI tract, including gastrointestinal regulatory peptides, neurotransmitters, neurotrophic factors, and gut microbiota. The findings of this study demonstrate that <i>L. rhamnosus</i> strains can alleviate constipation-related symptoms via different pathways independent of SCFAs regulation. This study yields a new perspective for clinical use of probiotics to better improve constipation symptoms, by combining strains with different mechanisms for alleviation of constipation.
immunology,microbiology
What problem does this paper attempt to address?